MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0022491
Ruby Biopharma Private Limited
Ruby Biopharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.92 Cr
▲ 24% YoY
Net profit · FY 2025
₹4.95 Cr
Net margin 12.1%
EBITDA · FY 2025
₹7.13 Cr
EBITDA margin 17.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹25.4 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Employees · EPFO
3
Provident fund records
About Ruby Biopharma Private Limited
Data last updated:
Ruby Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24234MH2008PTC178070. Its GSTIN is 05AADCR9760N1ZS (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Rumy Ravi Kumar and Ruby Ravi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11A Sandeep Park Deonar, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.92 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹4.95 Cr (net margin 12.1%) and EBITDA of ₹7.13 Cr (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 18% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25.4 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
Ruby Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0022491). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24234MH2008PTC178070
Registration Number 178070
Incorporation Date 21 January 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0022491
Key People
Rumy Ravi Kumar Director Ruby Ravi Kumar Director Recognitions & Rankings of Ruby Biopharma
Contact details
Ruby Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address11A Sandeep Park Deonar, Mumbai, Maharashtra, India – 400088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ruby Biopharma Private Limited, buy the company report.
Comprehensive company report
Ruby Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ruby Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ruby Biopharma Private Limited, buy the company report.
Financials of Ruby Biopharma Private Limited
FY 2024 filings availableRuby Biopharma Private Limited reported revenue of ₹40.92 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹40.92 Cr ▲ 24%
Net profit · FY 2025
₹4.95 Cr margin 12.1%
EBITDA · FY 2025
₹7.13 Cr margin 17.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 15%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 36%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 24% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.95 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 12.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ruby Biopharma Private Limited, buy the company report.
Board of directors of Ruby Biopharma Private Limited
Ruby Biopharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rumy Ravi Kumar Also directs: Ruby Organics Private Limited, Ruby Bio-Tech Private Limited | Director | 21 Jan 2008 | 18 Years 9 Months | Current |
| Ruby Ravi Kumar Also directs: Ruby Organics Private Limited | Director | 21 Jan 2008 | 18 Years 9 Months | Current |
Peer comparison
Ruby Biopharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stuck Chemicals Private Limited | ₹41.23 Cr (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Relixir Pharmaceuticals Private Limited | ₹41.19 Cr (FY 2023) | 48.0% | Hyderabad, Telangana, India | |||
| Lenus Life Care Private Limited | ₹41.1 Cr (FY 2024) | -30.0% | Chamba Ghar, Himachal Pradesh, India | |||
| Amishi Drugs and Chemicals Private Limited | ₹41.08 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Macrotech Polychem Private Limited | ₹40.96 Cr (FY 2025) | 46.0% | Mumbai, Maharashtra, India | |||
| Ruby Biopharma Private Limitedthis company | ₹40.92 Cr (FY 2025) | ₹4.95 Cr | 12.1% | 24.0% | 3 | Mumbai, Maharashtra, India |
| Mod Hike Private Limited | ₹40.91 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Astam Healthcare Private Limited | ₹40.87 Cr (FY 2024) | -13.0% | Baddi, Himachal Pradesh, India | |||
| Sunrise Remedies Private Limited | ₹40.84 Cr (FY 2024) | 3.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ruby Biopharma Private Limited, buy the company report.
Auditor
Ruby Biopharma Private Limited is audited by Lalit M. Dhing & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Lalit M. Dhing & Co | FY 2023 | 105565W |
Shareholding
The shareholding of Ruby Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ruby Biopharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Dec 2024 | 101010079 | Axis Bank Limited | ₹14 Cr | Open | |
| 21 Mar 2024 | 100894143 | Axis Bank Limited | ₹6 Cr | Open | |
| 04 Mar 2024 | 100886643 | Axis Bank Limited | ₹5.4 Cr | Open |
Total charge records: 3 View all charges
Legal cases
Ruby Biopharma Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Total cases
3
Filed against the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Court case (Original Civil Suit) | Filed against the company by Jayesh Traders Private Limited | Disposed |
| District court, Dehradun, Uttarakhand | Court case (Original Civil Suits) | Filed against the company by Jayesh Tradex Pvt.Ltd | Disposed |
| District court, Warangal, Telangana | Criminal complaint | Filed against the company by The State of Ap Rep by the Inspector of Drugs | Disposed |
To see the full case history of Ruby Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ruby Biopharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 54 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 27)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Graham Blowpack Pvt.Ltd | |||
| an individual supplier | |||
| Himalayan Packaging Industries Private Limited | |||
| Mahadev Traders |
To see the full MSME payment records of Ruby Biopharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ruby Biopharma Private Limited has a workforce of 3 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
GST
Ruby Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AADCR9760N1ZS | Uttarakhand | Active | 10 Jul 2017 |
To see the full GST registrations and return filing status of Ruby Biopharma Private Limited, buy the company report.
Recent activity
Ruby Biopharma Private Limited has 4 board changes on record since 2008: 3 appointments and 1 cessation. The latest: Prabha Ravi Kumar ceased to be Director on 12 Apr 2016.
Charges
A charge with Axis Bank Limited amounted to Rs. 1,400.00 Lakh with Charge ID 101010079 was registered on 03 Dec 2024.
AGM
Ruby Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ruby Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Axis Bank Limited amounted to Rs. 600.00 Lakh with Charge ID 100894143 was registered on 21 Mar 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 540.00 Lakh with Charge ID 100886643 was registered on 04 Mar 2024.
Ceased
Prabha Ravi Kumar ceased to be Director.
Appointed
Prabha Ravi Kumar was appointed as Director.
Appointed
Ruby Ravi Kumar was appointed as Director.
Appointed
Rumy Ravi Kumar was appointed as Director.
Incorporation
21 Jan 2008
Ruby Biopharma Private Limited was registered on 21 Jan 2008 with Roc Mumbai & aged 18 years 9 months as per MCA records.
Frequently asked questions
Ruby Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 2008 (18+ years old) and is registered under CIN U24234MH2008PTC178070.
Ruby Biopharma has 2 current directors:
- Rumy Ravi Kumar - Director
- Ruby Ravi Kumar - Director
The latest financial statements of Ruby Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ruby Biopharma is 05AADCR9760N1ZS, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ruby Biopharma is U24234MH2008PTC178070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ruby Biopharma has 3 court cases on record: 3 filed against it.
Ruby Biopharma was incorporated on 21 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ruby Biopharma by revenue are Stuck Chemicals Private Limited, Relixir Pharmaceuticals Private Limited, Lenus Life Care Private Limited, Amishi Drugs and Chemicals Private Limited, Macrotech Polychem Private Limited and 3 more, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prabha Ravi Kumar ceased to be Director on 12 Apr 2016. Prabha Ravi Kumar was appointed as Director on 21 Jan 2008. Ruby Ravi Kumar was appointed as Director on 21 Jan 2008. Ruby Biopharma has 4 board changes on record in total.
Yes, Ruby Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0022491).
Ruby Biopharma has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 54 overdue payments to 27 micro and small suppliers. The latest return was filed on 30 Apr 2024.
The registered office of Ruby Biopharma is at 11A Sandeep Park Deonar, Mumbai, Maharashtra, India – 400088.